These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2595195)

  • 1. Behavior of prealbumin in the acute phase of polymyalgia rheumatica treated with 6-methylprednisolone.
    Puccetti L; Lucchetti A; Barbieri P; Melchiorre D; Zuccotti M; Petrini G; Marotta G; Remorini E; Ciompi ML
    Ric Clin Lab; 1989; 19(3):251-8. PubMed ID: 2595195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of fibronectin in polymyalgia rheumatica giant cell arteritis.
    Puccetti L; Marotta G; Remorini E; Lucchetti A; Zuccotti M; Petrini G; Baicchi U; Ciompi ML
    Rheumatol Int; 1987; 7(6):249-54. PubMed ID: 3125593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.
    Burkel M; Arndt F; Schirmer JH; Moosig F; Holle JU
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):94-97. PubMed ID: 27974093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microheterogeneity of alpha 1-antichymotrypsin in the management of giant-cell arteritis and polymyalgia rheumatica.
    Hachulla E; Laine A; Hayem A
    Clin Sci (Lond); 1990 Jun; 78(6):557-64. PubMed ID: 2165887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
    Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF
    Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyalgia rheumatica: inflammation suppression with low dose of methylprednisolone or modified-release prednisone.
    Benucci M; Olivito B; Manfredi M; Meacci F; Infantino M; Li Gobbi F; Sarzi-Puttini P; Marcassa C; Atzeni F
    Eur Rev Med Pharmacol Sci; 2015; 19(5):745-51. PubMed ID: 25807425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum C-reactive protein in polymyalgia rheumatica. A prospective serial study.
    Mallya RK; Hind CR; Berry H; Pepys MB
    Arthritis Rheum; 1985 Apr; 28(4):383-7. PubMed ID: 2859021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of methotrexate in polymyalgia rheumatica.
    Feinberg HL; Sherman JD; Schrepferman CG; Dietzen CJ; Feinberg GD
    J Rheumatol; 1996 Sep; 23(9):1550-2. PubMed ID: 8877923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal arteritis after normalization of erythrocyte sedimentation rate in polymyalgia rheumatica.
    Papadakis MA; Schwartz ND
    Arch Intern Med; 1986 Nov; 146(11):2283-4. PubMed ID: 3778060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of antiphospholipid antibodies in Horton's disease and in polymyalgia rheumatica].
    Hulin C; Hachulla E; Michon-Pasturel U; Hatron PY; Masy E; Gillot JM; Caron C; Arvieux J; Flipo RM; Devulder B
    Rev Med Interne; 1999 Aug; 20(8):659-63. PubMed ID: 10480168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.
    Kyle V; Hazleman BL
    Ann Rheum Dis; 1989 Aug; 48(8):658-61. PubMed ID: 2782975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deflazacort versus methylprednisolone in polymyalgia rheumatica.
    Sáez Barcelona JA; Carmona Martín MM; Navarro López V
    J Rheumatol; 1996 Jul; 23(7):1306-7. PubMed ID: 8823716
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of polymyalgia rheumatica with intramuscular injections of depot methylprednisolone.
    Dasgupta B; Gray J; Fernandes L; Olliff C
    Ann Rheum Dis; 1991 Dec; 50(12):942-5. PubMed ID: 1768166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular Inflammation Associated with Polymyalgia Rheumatica without Concomitant Giant-Cell Arteritis: A Report of Three Cases.
    Arai T; Tanaka R; Kaburaki T
    Ocul Immunol Inflamm; 2018; 26(5):779-782. PubMed ID: 28282736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyalgia rheumatica: 125 years of progress?
    Rooney PJ; Rooney J; Balint G; Balint P
    Scott Med J; 2014 Nov; 59(4):220-8. PubMed ID: 25201885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyalgia rheumatica.
    McCabe ES
    J Am Geriatr Soc; 1976 Feb; 24(2):89-91. PubMed ID: 1249388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis.
    Park JR; Jones JG; Hazleman BL
    Ann Rheum Dis; 1981 Oct; 40(5):493-5. PubMed ID: 6171213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 in clinical relapses of polymyalgia rheumatica and giant cell arteritis.
    Caplanne D; Le Parc JM; Alexandre JA
    Ann Rheum Dis; 1996 Jun; 55(6):403-4. PubMed ID: 8694583
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis.
    Macchioni P; Boiardi L; Salvarani C; Rossi F; Casadei-Maldini M; Mancini R; Beltrandi E; Portioli I
    Br J Rheumatol; 1993 Aug; 32(8):666-70. PubMed ID: 8348267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombocytosis in polymyalgia rheumatica].
    Seyfarth B; Harten P; Löffler H
    Dtsch Med Wochenschr; 1996 Oct; 121(41):1255-60. PubMed ID: 8925762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.